Senhwa Biosciences Announces The Appointment Of Dr. Yiu-Lian Fong, The Former Global Head Of Janssen Diagnostic ...
(MENAFN- PR Newswire) TAIPEI and SAN DIEGO, Nov. 1, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced …